Literature DB >> 7026686

Novel preparation method of immunogen for hydrophobic hapten, enzyme immunoassay for daunomycin and adriamycin.

K Fujiwara, M Yasuno, T Kitagawa.   

Abstract

The present study was undertaken to develop a novel method of preparing a hydrophobic hapten as immunogen. The anticancer drug, daunomycin (DM) was used as prototype and coupled to mercaptosuccinylated bovine serum albumin (MS, BSA) with N-(gamma-maleimidobutyryloxy)succinimide (GMBS). Injection of rabbits with a conjugate (DM-GMBS-MS.BSA) which contained 7.3 DM per BSA molecule produced good levels of anti-DM antibody which was detected by the reaction of diluted antiserum with beta-D-galactosidase-labeled DM. beta-D-galactosidase-labeled DM was used to develop a double antibody enzyme immunoassay for DM and for the DM homologue adriamycin (AM) which reproducibly detected as little as 1 pmole of either drug. A variety of commonly used other anticancer drugs were tested and had little reactivity in this immunoassay. These studies indicate that the anti-DM serum produced is highly specific.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026686     DOI: 10.1016/0022-1759(81)90213-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  C-terminal topology of gastric H+,K(+)-ATPase.

Authors:  S Asano; S Arakawa; M Hirasawa; H Sakai; M Ohta; K Ohta; N Takeguchi
Journal:  Biochem J       Date:  1994-04-01       Impact factor: 3.857

2.  Synthesis of a covalent epirubicin-(C(3)-amide)-anti-HER2/neu immunochemotherapeutic utilizing a UV-photoactivated anthracycline intermediate.

Authors:  Cody P Coyne; Toni Jones; Ryan Bear
Journal:  Cancer Biother Radiopharm       Date:  2011-12-22       Impact factor: 3.099

3.  Distribution of anticancer antibiotic daunomycin in the rat heart and kidney revealed by immunocytochemistry using monoclonal antibodies.

Authors:  Kunio Fujiwara; Masashi Shin; David M Hougaard; Lars-Inge Larsson
Journal:  Histochem Cell Biol       Date:  2006-07-19       Impact factor: 4.304

4.  Selective killing of carcinoembryonic-antigen (CEA)-producing cells in vitro by the immunoconjugate cytorhodin-S and CEA-reactive cytorhodin-S antibody CA208.

Authors:  T Iwahashi; Y Tone; J Usui; H Watanabe; I Sugawara; S Mori; H Okazaki
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

5.  Synthesis of Gemcitabine-(C4-amide)-[anti-HER2/neu] Utilizing a UV-Photoactivated Gemcitabine Intermediate: Cytotoxic Anti-Neoplastic Activity against Chemotherapeutic-Resistant Mammary Adenocarcinoma SKBr-3.

Authors:  Cody P Coyne; Toni Jones; Ryan Bear
Journal:  J Cancer Ther       Date:  2012-10

6.  Light-microscopic immunocytochemistry for gentamicin and its use for studying uptake of the drug in kidney.

Authors:  Kunio Fujiwara; Masashi Shin; Hayato Matsunaga; Tetsuya Saita; Lars-Inge Larsson
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

7.  Immunocytochemistry for vancomycin using a monoclonal antibody that reveals accumulation of the drug in rat kidney and liver.

Authors:  Kunio Fujiwara; Yohei Yoshizaki; Masashi Shin; Tsubasa Miyazaki; Tetsuya Saita; Shuichi Nagata
Journal:  Antimicrob Agents Chemother       Date:  2012-09-04       Impact factor: 5.191

8.  Development of immunohistochemistry for detecting fluvoxamine in rat tissues using newly prepared monoclonal antibody: its precise localization in small intestine, kidney, and liver of rats.

Authors:  Masashi Shin; Yutaro Yamamoto; Hiroto Kataoka; Tetsuya Saita
Journal:  Med Mol Morphol       Date:  2022-10-11       Impact factor: 2.070

9.  Export of recombinant proteins in Escherichia coli using ABC transporter with an attached lipase ABC transporter recognition domain (LARD).

Authors:  Chan Woo Chung; Jinsun You; Kyeongyeon Kim; Yuseok Moon; Hoeon Kim; Jung Hoon Ahn
Journal:  Microb Cell Fact       Date:  2009-01-29       Impact factor: 5.328

10.  Metabolism and disposition of oseltamivir (OS) in rats, determined by immunohistochemistry with monospecific antibody for OS or its active metabolite oseltamivir carboxylate (OC): A possibility of transporters dividing the drugs' excretion into the bile and kidney.

Authors:  Kunio Fujiwara; Yutaro Yamamoto; Tetsuya Saita; Senya Matsufuji
Journal:  Pharmacol Res Perspect       Date:  2020-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.